Ningxia Zhongke Biotechnology Co., Ltd

SHSE:600165 Stock Report

Market Cap: CN¥1.3b

Ningxia Zhongke Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 600165?
Owner TypeNumber of SharesOwnership Percentage
Institutions23,631,6823.45%
Private Companies205,600,00030%
General Public455,652,09366.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 33.47% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.2%
Shanghai Zhongneng Enterprise Development (Group) Co., Ltd.
200,000,000CN¥378.0m0%no data
1.15%
Yingshui Investment Co., Ltd.
7,861,100CN¥14.9m0%0.34%
0.81%
CITIC Securities Company Limited, Asset Management Arm
5,562,573CN¥10.5m0%0.01%
0.66%
China International Capital Corporation Hong Kong Asset Management Limited
4,514,459CN¥8.5m0%0.05%
0.57%
Ningxia Computer Software and Technology Service Co., Ltd.
3,900,000CN¥7.4m0%no data
0.49%
UBS Asset Management AG
3,355,765CN¥6.3m0%no data
0.34%
Goldman Sachs Group, Investment Banking and Securities Investments
2,296,185CN¥4.3m0%no data
0.25%
Shenzhen Longda New Energy Co., Ltd.
1,700,000CN¥3.2m0%no data
0.0061%
Fortune And Royal Asset Management Co., Ltd.
41,600CN¥78.6k0%no data